Stock Price Targets and Analyst Ratings

Stay on top of the latest U.S. and international stock analyst recommendations with our up-to-date list of stock price targets and analyst ratings. This page tracks newly issued analyst ratings, price targets, upgrades, downgrades, and other broker actions to help you see how Wall Street analysts view the companies you follow. Use these ratings to compare sentiment, spot shifts in outlook, and make more informed investment decisions.

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
0RYA Ryanair Holdings (cdi)	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,982.42 -0.9%	GBX 29 ➝ GBX 29	Outperform
AAL Anglo American	Target Lowered by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 3,675 -2.8%	GBX 4,100 ➝ GBX 4,000	Buy
ACM AECOM	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adam Seiden Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$71.07 -0.6%	$110.00 ➝ $90.00	Equal Weight
ACQ AutoCanada	Target Lowered by	ATB Cormark Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$20.74 -3.4%	C$22.00 ➝ C$21.00	Sector Perform
ADC Agree Realty	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Hightower Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$75.59 -0.2%	$86.00 ➝ $84.00	Equal Weight
AGYS Agilysys	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mayank Tandon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$78.94 +12.5%	$120.00	Buy
AGYS Agilysys	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Schwartz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$78.94 +12.5%	$90.00 ➝ $100.00	Outperform
ALAB Astera Labs	Reiterated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$244.26 +13.3%	$297.00	Outperform
ALMS Alumis	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$21.52 +1.7%		Buy
ALMS Alumis	Target Raised by	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Janani Sundararajan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.52 +1.7%	$38.00 ➝ $40.00	Buy
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ALNY Alnylam Pharmaceuticals	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Joseph Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$294.30 +2.8%	$380.00	Buy
AMAT Applied Materials	Target Raised by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Kelleher Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$406.91 -1.6%	$420.00 ➝ $500.00	Buy
AMC AMC Entertainment	Target Set by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Handler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.37 +0.4%	$1.50
AMD Advanced Micro Devices	Reiterated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$414.05 -1.6%	$579.00	Outperform
AMH American Homes 4 Rent	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Goldsmith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.73 -0.5%	$33.00 ➝ $32.00	Neutral
AMRC Ameresco	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manish A. Somaiya Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.01 -6.5%	$41.00 ➝ $45.00	Overweight
AMS Advanced Medical Solutions Group	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 207.58 +3.0%	GBX 300 ➝ GBX 300	Buy
AMT American Tower	Upgraded by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Madison Rezaei Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$182.86 +3.1%	$207.00	Market Perform ➝ Outperform
ANIC Agronomics	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 6.75	GBX 14 ➝ GBX 13.30	Buy
ANIOY Acerinox	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.38		Overweight
APA APA	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$40.91 +1.9%	$31.00 ➝ $34.00	Sell
ARE Alexandria Real Estate Equities	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$45.86 -1.8%	$52.00	Neutral
ARMK Aramark	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gary Bisbee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$51.54 -2.6%	$54.00 ➝ $59.00	Buy
ARX Accelerant	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Newsome Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.53 +3.9%	$13.00 ➝ $18.00	Overweight
AS Amer Sports	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$33.77 +1.9%	$50.00
ASML ASML	Upgraded by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1,459.44 -0.9%		Buy
AVGO Broadcom	Reiterated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$411.07 -2.3%	$582.00	Outperform
BAP Credicorp	Upgraded by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Carlos Gomez-Lopez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$314.86 +3.6%	$320.00 ➝ $350.00	Hold ➝ Buy
BBIO BridgeBio Pharma	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Joseph Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$66.00 +1.0%	$82.00	Neutral
BC Brunswick	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Megan Alexander Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.55 -3.8%	$82.00 ➝ $86.00	Equal Weight
BDT Bird Construction	Target Raised by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$58.68 +0.6%	C$52.00 ➝ C$61.00
BDT Bird Construction	Target Raised by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$58.68 +0.6%	C$63.00 ➝ C$72.00	Buy
BEEP Mobile Infrastructure	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Steinke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.25 +10.3%	$6.50	Outperform
BEKE KE	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$18.68 +4.9%		Buy
BESIY BE Semiconductor Industries	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$297.10 -1.2%		Overweight
BIDU Baidu	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Fawne Jiang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$137.68 0.0%	$215.00	Buy
BIDU Baidu	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$137.68 0.0%	$135.00 ➝ $140.00
BILL BILL	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Coad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.76 -2.0%	$46.00 ➝ $45.00	Buy
BMRN BioMarin Pharmaceutical	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Joseph Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.84 +0.3%	$75.00	Buy
BMRN BioMarin Pharmaceutical	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Zemansky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.84 +0.3%	$85.00 ➝ $80.00	Buy
SpaceX will mint billionaires. You won't be one of them. (Ad) By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billion - you'd be buying at $1.75 trillion. But one small, publicly traded company sits directly in SpaceX's path, still priced like Wall Street hasn't noticed. It powers the infrastructure Musk's operation can't run without. Dylan Jovine is naming the ticker free - before the June S-1 closes the window. Get the ticker now before the June S-1 closes the window
BN Brookfield	Target Raised by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$44.30 -1.7%	$59.00 ➝ $60.00	Buy
BN Brookfield	Reiterated by	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$44.30 -1.7%	$60.00	Buy
BRBY Burberry Group	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,084.88 +0.2%	GBX 1,400 ➝ GBX 1,400	Outperform
BSX Boston Scientific	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Rescott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.78 +1.5%	$78.00 ➝ $75.00	Outperform
BUD Anheuser-Busch InBev SA/NV	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$81.90 +0.7%		Buy
BXBLY Brambles	Upgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$25.13 -3.9%	$19.34	Neutral
BXSL Blackstone Secured Lending Fund	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Arren Cyganovich Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.56 -0.4%	$30.00 ➝ $26.00	Buy
BYG Big Yellow Group	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 812 -2.1%	GBX 1,323 ➝ GBX 1,323	Buy
CAN Canaan	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Lewis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.42 -13.6%	$3.00	Buy
CCOI Cogent Communications	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Rollins Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.68 +2.7%	$22.00 ➝ $20.00	Neutral
CCR C&C Group	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 105 -3.7%		Buy
CELH Celsius	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$29.13 -0.7%		Buy
CGEM Cullinan Therapeutics	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julian Harrison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.18 -4.6%	$38.00	Buy
CGON CG Oncology	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kalpit Patel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$63.30 +0.6%		Peer Perform
CGY Calian Group	Target Raised by	ATB Cormark Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$80.88 +0.3%	C$92.50 ➝ C$98.50	Outperform
CIFR Cipher Mining	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Byrd Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.80 -1.7%	$42.50	Overweight
CING Cingulate	Reiterated by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boobalan Pachaiyappan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.39 -2.0%	$10.00	Buy
COST Costco Wholesale	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rupesh Parikh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,094.32 +1.7%	$1,100.00 ➝ $1,160.00	Outperform
CRCL Circle Internet Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Faucette Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$111.36 0.0%	$80.00 ➝ $106.00	Equal Weight
CRCL Circle Internet Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Faucette Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$111.36 0.0%	$80.00 ➝ $106.00	Equal Weight
CRNT Ceragon Networks	Reiterated by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.53 +0.8%	$4.50	Buy
CSCO Cisco Systems	Target Raised by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$115.38 -2.9%	$100.00 ➝ $150.00	Buy
CSGP CoStar Group	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Heather Balsky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.80 +1.8%	$42.00 ➝ $37.00	Neutral
CSX CSX	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Moore Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.10 -0.2%	$47.00 ➝ $49.00	Outperform
CSX CSX	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Hoexter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.10 -0.2%	$49.00 ➝ $51.00	Buy
CTMX CytomX Therapeutics	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.64 +4.0%	$6.00	Outperform
CURY Currys	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 145.70 +15.3%	GBX 210 ➝ GBX 210	Buy
CVE Cenovus Energy	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$43.70 +3.0%	C$45.00 ➝ C$47.00	Outperform
CVE Cenovus Energy	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Greg Pardy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.84 +0.9%	$45.00 ➝ $47.00	Outperform
CWK Cranswick	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 5,500 +5.2%		House Stock
D Dominion Energy	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen D'Ambrisi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$68.10 +0.8%	$66.00 ➝ $72.00	Sector Perform
DELL Dell Technologies	Target Raised by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$235.42 -1.1%	$240.00 ➝ $270.00	Outperform
DHT.UN DRI Healthcare Trust	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$16.09 -0.3%	C$25.00 ➝ C$30.00	Sector Outperform
DHT.UN DRI Healthcare Trust	Target Raised by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$16.09 -0.3%	C$22.50 ➝ C$23.50	Outperform
DHT.UN DRI Healthcare Trust	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$16.09 -0.3%	C$22.00 ➝ C$23.00	Buy
DIV Diversified Royalty	Target Raised by	Desjardins Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$4.67 +8.4%	C$4.50 ➝ C$4.75	Buy
DOCS Dr. Martens	Target Lowered by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 66.40 +3.3%	GBX 114 ➝ GBX 110	Buy
DPLM Diploma	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 6,835 +3.2%	GBX 7,500 ➝ GBX 9,000	Buy
DPRO Draganfly	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Austin Bohlig Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.27	$12.00	Buy
DRTS Alpha Tau Medical	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Bednar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.68 +6.5%	$5.00 ➝ $8.00	Neutral
DWTX Dogwood Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sean Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.85 +8.8%	$12.00	Buy
ECL Ecolab	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ashish Sabadra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$245.61 -1.4%	$337.00	Outperform
ECL Ecolab	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Haas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$245.61 -1.4%	$285.00 ➝ $260.00	Equal Weight
EFX Equifax	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Curtis Nagle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$160.78 -2.1%	$250.00 ➝ $225.00	Buy
ELEZY Endesa	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$20.91 -2.3%		Sell
ELF e.l.f. Beauty	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anna Andreeva Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$52.82 -3.7%	$85.00 ➝ $60.00	Neutral
ELV Elevance Health	Reiterated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$402.32 +2.1%		Hold
ENLAY Enel	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.08 -1.6%		Neutral
ESTC Elastic	Target Lowered by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Howard Ma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$53.79 -0.2%	$116.00 ➝ $106.00	Buy
EVTC Evertec	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Faucette Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.28 +0.0%	$29.00 ➝ $25.00	Equal Weight
The chokepoint supplier behind SpaceX's $1.75 trillion empire (Ad) When Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession. The world's largest supercomputer requires power equipment that takes 120 weeks to build, and Musk built Colossus in just 122 days. One small American company is positioned to close that gap faster than anyone else, yet Wall Street still prices it like an afterthought. Dylan Jovine has the full story and the ticker. See the stock Musk's own words pointed to right here
FATE Fate Therapeutics	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1.89 +9.2%		Buy
FATE Fate Therapeutics	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1.89 +9.2%	$4.00
FCN FTI Consulting	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$154.73 +0.7%	$169.00
FDY Faraday Copper	Target Set by	Ventum Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$5.57 -1.2%	C$7.00	Buy
FFIV F5	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Hedberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$383.50 +1.0%	$375.00 ➝ $425.00	Outperform
FICO Fair Isaac	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Curtis Nagle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,186.17 +0.4%	$1,550.00 ➝ $1,400.00	Buy
FINGF Finning International	Reiterated by	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$70.21 -6.2%		Buy
FLYW Flywire	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Coad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.83 -1.2%	$16.00 ➝ $18.00	Buy
FM First Quantum Minerals	Upgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$34.00 -2.4%	C$37.70 ➝ C$42.20	Equal ➝ Overweight
FRT Federal Realty Investment Trust	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicholas Yulico Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$114.86 -0.1%	$118.00 ➝ $128.00	Sector Outperform
FRT Federal Realty Investment Trust	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicholas Yulico Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$114.86 -0.1%	$118.00 ➝ $128.00	Outperform
FTNT Fortinet	Downgraded by	DZ Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$127.64 +0.9%	$125.00	Buy ➝ Hold
FTT Finning International	Target Raised by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$95.80 -6.3%	C$106.00 ➝ C$115.00	Buy
GEHC GE HealthCare Technologies	Target Lowered by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$61.56 +0.1%	$95.00 ➝ $80.00	Buy
GFS GlobalFoundries	Reiterated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$66.68 -1.7%	$85.00	Outperform
GHRS GH Research	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.94 +1.2%	$70.00 ➝ $65.00	Buy
GILD Gilead Sciences	Target Lowered by	Daiwa Securities Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$130.50 +0.6%	$161.00 ➝ $150.00	Outperform
GOLF Acushnet	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Miller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$87.62 +1.9%	$95.00 ➝ $97.00	Hold
GPN Global Payments	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Coad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$67.84 -1.2%	$81.00 ➝ $76.00	Hold
GRBK Green Brick Partners	Reiterated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James McCanless Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$63.53 +0.1%		Market Perform
GS The Goldman Sachs Group	Target Raised by	CICC Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$927.61 -2.0%	$825.00 ➝ $980.00	Outperform
GSBD Goldman Sachs BDC	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Hughes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.78 +0.3%	$10.00 ➝ $9.00	Hold
GTLB GitLab	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adam Tindle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.46 +1.5%		Market Perform
GTM ZoomInfo Technologies	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Bullock Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.81 -2.8%	$4.00	Underperform
HCA HCA Healthcare	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$403.98 -4.4%	$535.00 ➝ $490.00	Neutral
HD Home Depot	Target Lowered by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Bottiglieri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$302.23 +0.8%	$348.00 ➝ $325.00	Neutral
HD Home Depot	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Matuszewski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$302.23 +0.8%	$454.00 ➝ $361.00	Buy
HD Home Depot	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scot Ciccarelli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$302.23 +0.8%	$369.00
HD Home Depot	Reiterated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$302.23 +0.8%	$365.00	Outperform
HD Home Depot	Target Set by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Baker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$302.23 +0.8%	$377.00
HFG Hilton Food Group	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 554.50 +2.7%		House Stock
HIMS Hims & Hers Health	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Allen Lutz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.47 +0.8%	$30.00 ➝ $28.00	Neutral
HIVE HIVE Digital Technologies	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Knoblauch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.35 -3.2%	$3.00 ➝ $4.60	Overweight
HOG Harley-Davidson	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adam Jonas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.45 -3.7%	$12.00 ➝ $15.00	Underweight
HOMB Home BancShares	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dave Rochester Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.11 +0.1%	$31.00 ➝ $30.00	Neutral
HPP Hudson Pacific Properties	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Caitlin Burrows Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.68 -1.1%	$7.50 ➝ $12.00	Neutral
HUN Huntsman	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.32 -3.6%	$15.00	Hold
HYFT MindWalk	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.26	$5.00	Buy
IFP Interfor	Target Lowered by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$8.82 +2.9%	C$12.00 ➝ C$10.00	Hold
IMRX Immuneering	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.89 +0.4%	$20.00	Buy
IMTX Immatics	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.70 +0.8%	$25.00	Buy
INVH Invitation Home	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Goldsmith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.65 -0.4%	$35.00 ➝ $32.00	Buy
IPGP IPG Photonics	Reiterated by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$113.47 +6.7%	$151.00	Buy
IQ iQIYI	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Fawne Jiang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.11 -1.8%		Hold
J Jacobs Solutions	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sabahat Khan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$112.80 -0.7%	$169.00	Outperform
JAZZ Jazz Pharmaceuticals	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ashwani Verma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$237.45 +3.4%	$188.00 ➝ $307.00	Neutral ➝ Buy
JBS JBS	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$12.45 -3.2%	$17.00
JRVR James River Group	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Meredith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.06 -7.2%	$8.00 ➝ $4.75	Buy ➝ Neutral
JSE Jadestone Energy	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 32 +2.4%	GBX 74 ➝ GBX 74	Buy
KEP Korea Electric Power	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.12 +1.7%		Equal Weight ➝ Underweight
Trump's gold order: the announcement they won't put on the front page (Ad) On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free. Request the free guide in 30 seconds and get positioned now
KEY Keyera	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$58.71 +2.2%	C$65.00	Buy
KIM Kimco Realty	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Greg McGinniss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.34 -0.6%	$24.00 ➝ $25.00	Sector Perform
KNOS Kainos Group	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 846 +3.2%	GBX 1,150 ➝ GBX 1,200	Buy
KNOS Kainos Group	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 846 +3.2%	GBX 1,185 ➝ GBX 1,185	Buy
KNRRY Knorr-Bremse	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$29.38 -0.5%		Neutral ➝ Buy
KRMN Karman	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clarke Jeffries Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$63.82 -3.6%	$127.00 ➝ $114.00	Overweight
KRRO Korro Bio	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.15 -8.3%	$20.00 ➝ $15.00	Buy
LGN LGN	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adam Seiden Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.38 -3.5%	$45.00 ➝ $60.00	Equal Weight
LGN LGN	Target Raised by	Tigress Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ivan Feinseth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.38 -3.5%	$85.00 ➝ $125.00	Buy
LSPD Lightspeed Commerce	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Bullock Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.65 -3.4%	$10.00	Buy ➝ Underperform
LUCE Luceco	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 240 +2.1%	GBX 200 ➝ GBX 270	Buy
LUNR Intuitive Machines	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Sheppard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$32.46 -3.4%	$26.00 ➝ $43.00	Overweight
MAC Macerich	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Greg McGinniss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.95 +0.3%	$22.00 ➝ $24.00	Outperform
MAC Macerich	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Greg McGinniss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.95 +0.3%	$22.00 ➝ $24.00	Sector Outperform
MAIN Main Street Capital	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Hughes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.53 -0.9%	$60.00 ➝ $53.00	Hold
MARA Marathon Digital	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Byrd Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.44 +2.1%	$8.50 ➝ $7.00	Underweight
MDB MongoDB	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$334.68 +1.4%	$350.00 ➝ $375.00
MDB MongoDB	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$334.68 +1.4%	$395.00	Outperform
MIRM Mirum Pharmaceuticals	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kalpit Patel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$95.65 +0.2%	$145.00	Outperform
MMYT MakeMyTrip	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijit Jain Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.46 -7.7%		Buy
MOS Mosaic	Reiterated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Isaacson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.39 -0.1%	$30.00	Outperform
MOS Mosaic	Target Lowered by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$21.39 -0.1%	$28.00 ➝ $27.00	Hold
MOS Mosaic	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Isaacson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.39 -0.1%	$33.00 ➝ $30.00
MRVL Marvell Technology	Reiterated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$176.27 +4.3%	$155.00	Outperform
MS Morgan Stanley	Target Raised by	CICC Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$189.58 -1.6%	$175.00 ➝ $200.00	Outperform
MSIF MSC Income Fund	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Arren Cyganovich Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.95 +0.2%	$16.00 ➝ $14.00	Buy
MSTR Strategy	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lance Vitanza Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$164.63 -1.2%	$395.00 ➝ $400.00	Buy
MTRN Materion	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Samuel McKinney Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$194.87 -3.7%	$185.00 ➝ $223.00	Overweight
MU Micron Technology	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$698.74 +2.5%	$800.00	Outperform
MU Micron Technology	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Atif Malik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$698.74 +2.5%	$425.00 ➝ $840.00	Buy
NCLH Norwegian Cruise Line	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robin Farley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.78 -3.2%	$22.00 ➝ $17.00	Neutral
NEE NextEra Energy	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Arcaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$90.03 +1.1%	$107.00 ➝ $115.00	Overweight
NOA North American Construction Group	Reiterated by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$14.76 -4.8%		Neutral
NVDA NVIDIA	Reiterated by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Frank Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$220.61 -0.8%	$295.00 ➝ $325.00	Buy
OBDC Blue Owl Capital	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Arren Cyganovich Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.06 +0.4%	$15.00 ➝ $13.00	Buy
OBIO Orchestra BioMed	Target Lowered by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Bauser Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.00 +0.5%	$12.00 ➝ $10.00	Buy
OKLO Oklo	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Fleishman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.00 -4.4%		Peer Perform
ON onsemi	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$106.02 -3.1%	$120.00 ➝ $130.00	Outperform
ONDS Ondas	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Austin Bohlig Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.13 -5.9%	$23.00	Buy
ONEX Onex	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$103.94 -4.4%	C$136.00 ➝ C$130.00	Sector Perform
OSTX OS Therapies	Target Lowered by	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chad Messer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.76 +1.7%	$14.00 ➝ $13.00	Buy
OTB On the Beach Group	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 136 +3.0%	GBX 305 ➝ GBX 290	Outperform
OTF Blue Owl Technology Finance	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Arren Cyganovich Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.98 +0.0%	$16.00 ➝ $15.00	Buy
PANW Palo Alto Networks	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Junaid Siddiqui Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$240.13 -3.0%	$200.00 ➝ $275.00	Buy
PANW Palo Alto Networks	Target Raised by	Capital One Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$240.13 -3.0%	$168.00 ➝ $248.00	Equal Weight
PBEE PensionBee Group	Upgraded by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 140	GBX 170 ➝ GBX 175	Sector perform
PDFS PDF Solutions	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Blair Abernethy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.57 -2.5%	$52.00	Buy
PFG Principal Financial Group	Downgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Wilma Burdis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$101.14 -1.2%	$99.00 ➝ $111.00	Strong-Buy ➝ Outperform
PFLT PennantPark Floating Rate Capital	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Arren Cyganovich Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.26 -1.1%	$10.00 ➝ $9.00	Buy
PGNY Progyny	Upgraded by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Close Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.60 +2.3%	$19.00 ➝ $30.00	Hold ➝ Buy
Iran's New Leader Just Said Something That Should Terrify Every American (Ad) Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of the world's oil passing through that corridor, crude has already crossed $100 per barrel. History shows gold surged 571% during the 1973 oil crisis and 425% in 1979. Today, the U.S. holds 8,133 tonnes of gold valued on the books at $42.22 per ounce - while gold trades above $5,000. American Alternative Assets has released The Great Gold Reset report detailing what this gap could mean for investors. Claim your free copy of The Great Gold Reset report today
PII Polaris	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Grambling Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$60.04 -6.2%	$74.00 ➝ $69.00	Equal Weight
PLUG Plug Power	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Blum Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.31 -4.1%	$2.00 ➝ $2.50	Equal Weight
PNFP Pinnacle Financial Partners	Target Set by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$94.36 -0.5%	$115.00
PNNT PennantPark Investment	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Arren Cyganovich Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.87 -5.0%	$6.00 ➝ $5.00	Buy
PPC Pilgrim's Pride	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matheus Enfeldt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.40 +0.1%	$30.00	Neutral
PRIM Primoris Services	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manish A. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$104.78 -3.5%	$113.00 ➝ $124.00	Neutral
PRV.UN PRO Real Estate Investment Trust	Target Raised by	Desjardins Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$2.30 +0.4%	C$6.50 ➝ C$6.75	Hold
PSX Phillips 66	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$182.59 +1.6%	$207.00	Neutral
PXED Phoenix Education Partners	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexander Paris Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.17 +0.6%	$45.00	Outperform
PZA Pizza Pizza Royalty	Target Lowered by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$12.95 -6.3%	C$14.00 ➝ C$12.00	Hold
RAMP LiveRamp	Downgraded by	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$37.72 -0.1%	$38.50	Buy ➝ Hold
RBC RBC Bearings	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kristine Liwag Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$566.60 +2.8%	$600.00 ➝ $640.00	Overweight
RBC RBC Bearings	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexandra Mandery Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$566.60 +2.8%	$599.00 ➝ $615.00	Buy
REGN Regeneron Pharmaceuticals	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Newman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$630.30 +0.1%	$1,057.00 ➝ $875.00	Buy
RGL Regional REIT	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 89.39 +0.4%		House Stock
RLAY Relay Therapeutics	Target Raised by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dane Leone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.07 -0.2%	$23.00 ➝ $26.00	Strong-Buy
RLAY Relay Therapeutics	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$12.07 -0.2%	$26.00
RLAY Relay Therapeutics	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$12.07 -0.2%		Strong-Buy
RUSHA Rush Enterprises	Reiterated by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brady Lierz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$68.60 -0.2%	$85.00	Overweight
RYAAY Ryanair	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$54.16 -3.4%		Buy
RYAAY Ryanair	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$54.16 -3.4%		Outperform
RYN Rayonier	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Wilde Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.95 +0.5%	$26.00 ➝ $25.00	Market Perform
SGMT Sagimet Biosciences	Target Lowered by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Wolleben Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.54 -1.8%	$35.00 ➝ $12.00	Market Outperform
SIRI Sirius XM	Target Lowered by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Barton Crockett Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.05 -0.2%	$46.00 ➝ $45.00	Buy
SJM J. M. Smucker	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Palmer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$102.98 -0.6%	$130.00 ➝ $120.00	Overweight
SKT Tanger	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicholas Yulico Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.05 -1.7%	$36.00 ➝ $37.00	Sector Perform
SLNO Soleno Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kristen Kluska Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$53.01		Neutral
SNDK Sandisk	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Asiya Merchant Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,383.29 +3.8%	$1,300.00 ➝ $2,025.00	Buy
SNOW Snowflake	Reiterated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$169.36 +3.1%	$325.00	Market Outperform
SPB Superior Plus	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$7.54 -0.9%	C$7.00 ➝ C$8.50	Sector Perform
SPG Simon Property Group	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicholas Yulico Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$200.84 +0.2%	$192.00 ➝ $206.00	Sector Perform
SPG Simon Property Group	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Hightower Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$200.84 +0.2%	$201.00 ➝ $212.00	Equal Weight
SPHR Sphere Entertainment	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler DiMatteo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$135.21 -1.6%	$190.00	Buy
SSPG SSP Group	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 162.30 +4.4%		House Stock
STM STMicroelectronics	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$61.29 +0.5%	$56.00 ➝ $68.00	Outperform
STN Stantec	Target Lowered by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$105.72 -0.6%	C$173.00 ➝ C$160.00
STN Stantec	Reiterated by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$76.89 -0.5%		Outperform
STUB STUB	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.48 +1.6%		Neutral ➝ Buy
STUB STUB	Upgraded by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.48 +1.6%		Outperform
STUB STUB	Downgraded by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.48 +1.6%		Outperform ➝ Market Perform
STUB STUB	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.48 +1.6%		Neutral
STUB STUB	Downgraded by	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.48 +1.6%		Hold
STUB STUB	Upgraded by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.48 +1.6%		Buy
STUB STUB	Upgraded by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Curry Baker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.48 +1.6%	$8.50 ➝ $12.50	Neutral ➝ Buy
TENB Tenable	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Saket Kalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.25 +9.2%	$21.00 ➝ $27.00	Equal Weight
THG The Hanover Insurance Group	Downgraded by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Zaremski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$193.95 -1.8%	$194.00 ➝ $203.00	Outperform ➝ Market Perform
TILE Interface	Initiated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reuben Garner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.37 -4.0%	$36.00	Buy
TLN Talen Energy	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicholas Campanella Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$314.57 -3.0%	$408.00 ➝ $411.00	Overweight
TMUS T-Mobile US	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sebastiano Petti Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$193.42 +1.5%		Buy
TPK Travis Perkins	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 512 +0.9%	GBX 680 ➝ GBX 630	Overweight
TRI Thomson Reuters	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Curtis Nagle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$87.35 -2.9%	$115.00 ➝ $98.00	Neutral
TRU TransUnion	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Curtis Nagle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$66.32 -3.3%	$83.00 ➝ $80.00	Neutral
TSCO Tractor Supply	Target Lowered by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$31.14 -1.8%	$50.00 ➝ $45.00	Outperform
TVE Tamarack Valley Energy	Target Set by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$13.42 +0.6%	C$15.00	Buy
TVK TerraVest Industries	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$127.11 -4.2%	C$192.00 ➝ C$190.00	Buy
TVK TerraVest Industries	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$127.11 -4.2%	C$178.00 ➝ C$172.00	Sector Outperform
TX Ternium	Upgraded by	Bradesco Corretora Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$42.18 -1.6%	$62.00	Outperform
TXN Texas Instruments	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$302.31 +0.6%	$255.00 ➝ $300.00	Neutral
TYRA Tyra Biosciences	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kalpit Patel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.78 -5.3%		Peer Perform
UNIT Uniti Group	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Rollins Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.67 -1.2%	$9.00 ➝ $11.75	Neutral
USAS Americas Gold and Silver	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$5.65 -2.8%		Outperform
VECO Veeco Instruments	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tom O'Malley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.69 -1.7%	$30.00 ➝ $55.00	Equal Weight
VET Vermilion Energy	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$18.17 +3.1%	C$22.00 ➝ C$24.00	Sector Perform
VET Vermilion Energy	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.21 +1.7%		Sector Perform
VIC Victorian Plumbing Group	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 74.90 -4.6%	GBX 115 ➝ GBX 115	Buy
VRSK Verisk Analytics	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Dennerlein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$170.71 -0.5%	$225.00 ➝ $190.00	Neutral
VRTS Virtus Investment Partners	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Cyprys Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$132.82 -5.3%	$128.00 ➝ $112.00	Underweight
VTR Ventas	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$88.38 +0.3%	$110.00	Buy
VTY Vistry Group	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 254.60 -3.8%	GBX 530 ➝ GBX 430	Neutral
W Wayfair	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ronald Josey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$57.53 -2.9%	$110.00 ➝ $95.00	Buy
WATR Water Intelligence	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 247.50 -1.0%	GBX 515 ➝ GBX 515	Buy
WOSG Watches of Switzerland Group	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 648.61 -1.0%	GBX 560 ➝ GBX 650	Sector perform
WPC W.P. Carey	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rich Hightower Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$74.49 +0.8%	$72.00 ➝ $78.00	Underweight
WRBY Warby Parker	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$25.37 -11.4%		Overweight
WULF TeraWulf	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Byrd Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.34 +0.9%	$42.00	Overweight
WVE WAVE Life Sciences	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.14 -4.1%	$18.00 ➝ $13.00	Buy
XE X-Energy	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeremy Tonet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.77 +4.6%	$38.00	Overweight
XE X-Energy	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$26.77 +4.6%	$38.00	Overweight
XE X-Energy	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julien Dumoulin-Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.77 +4.6%	$28.00	Hold
XE X-Energy	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Arcaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.77 +4.6%	$41.00	Overweight
XE X-Energy	Initiated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Osha Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.77 +4.6%	$57.00	Buy
XE X-Energy	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jon Windham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.77 +4.6%	$40.00	Buy
XE X-Energy	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Fleishman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.77 +4.6%		Peer Perform
XE X-Energy	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marc Bianchi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.77 +4.6%	$35.00	Buy
YETI YETI	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Megan Alexander Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.89 -1.3%	$47.00 ➝ $48.00	Equal Weight
ZETA Zeta Global	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Bullock Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.22 -5.0%	$24.00	Buy
ZM Zoom Communications	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	William Power Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$97.39 -1.5%	$95.00 ➝ $105.00	Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 01:07 AM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings